Novel Iron Prochelators for Protection Against Oxidative Stress in RPE Cells

用于保护 RPE 细胞免受氧化应激的新型铁预螯合剂

• 批准号: 7451925
• 负责人: JOSHUA L DUNAIEF
• 金额: $ 24.95万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-03-01 至 2010-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7451925
• 关键词: Affinity; Age related macular degeneration; Aging; Antibodies; Atherosclerosis; Binding; Biochemical Markers; Buthionine Sulfoximine; Cell Death; Cell Survival; Cells; Cessation of life; Characteristics; Chelating Agents; Chemicals; Cytoprotection; DNA; Data; Diabetes Mellitus; Disease; Future; Glutathione; Goals; Homeostasis; Hydrogen Peroxide; Hydroxyl Radical; Hydroxylation; Ions; Iron; Iron Chelation; Kinetics; Lead; Lipid Peroxidation; Masks; Mediating; Metabolism; Metals; Modeling; Modification; Mus; Nerve Degeneration; Numbers; Oxidants; Oxidative Stress; Oxygen; Patient Agents; Pharmaceutical Preparations; Post-Translational Protein Processing; Reaction; Retinal Degeneration; Site; Structure of retinal pigment epithelium; Testing; Toxic effect; Tube; Vascular Endothelial Growth Factors; base; buthionine; design; experience; improved; metalloenzyme; novel; prevent; salicylaldehyde isonicotinoyl hydrazone

DESCRIPTION (provided by applicant): Oxidative stress is implicated in a wide variety of diseases, including but not limited to age-related macular degeneration (AMD), diabetes, atherosclerosis, aging, and neurodegeneration. The biochemical markers of oxidative stress, including lipid peroxidation, DNA base hydroxylation, and protein modification, result primarily from reaction with the highly reactive hydroxyl radical, OH7, itself a product of iron-catalyzed reactions, with oxygen species. While iron is an essential and beneficial component of healthy cells, this deleterious reactivity suggests that any free iron in the cell will cause significant damage. Inhibiting metal-promoted oxidative stress is therefore a promising strategy for treating a number of diseases, especially those where normal metal ion homeostasis is impaired or where aberrant metal accumulation is documented, as is the case for AMD. Generalized iron chelation could protect against oxidative damage, but could also be detrimental if iron needed for metabolic processes is removed. We are designing chelating agents (prochelators) that are active only when needed: they selectively sequester and inactivate iron only in cells undergoing oxidative stress, thereby limiting oxidative damage in these cells. These chelators are chemical modifications of salicylaldehyde isonicotinoyl hydrazone (SIH), which we have found able to protect cultured retinal pigment epithelial cells (RPE) from death induced by a wide variety of insults. We propose herein to test in RPE cells the ability of several modified SIH molecules to decrease the labile iron pool selectively when cells are experiencing oxidative stress, and to determine whether the chelators increase cell viability. Preliminary results suggest that these prochelators are activated by oxidative stress both in the test tube and in RPE cells, and that they can protect cultured RPE cells from oxidant induced death. The goal of this proposal is to identify prochelators with the optimal characteristics: maximal RPE protection with minimal toxicity. These studies will lay the groundwork for future prochelator testing in mouse retinal degeneration models. It is hoped that these studies will lead to a new preventative agent for patients with early AMD.

描述（由申请人提供）：氧化应激与多种疾病有关，包括但不限于与年龄相关的黄斑变性（AMD），糖尿病，动脉粥样硬化，衰老和神经变性。氧化应激的生化标志物，包括脂质过氧化，DNA碱基羟基化和蛋白质修饰，主要是由与高反应性羟基自由基反应，OH7本身是铁催化反应的产物，与氧气催化反应。虽然铁是健康细胞的必不可少的成分，但这种有害的反应性表明细胞中的任何游离铁都会造成重大损害。因此，抑制金属促进的氧化应激是治疗多种疾病的有前途的策略，尤其是那些在正常金属离子稳态受损或记录了异常金属积累的地方，就像AMD一样。普遍的铁螯合可以预防氧化损伤，但如果去除代谢过程需要铁，也可能有害。我们正在设计仅在需要时活跃的螯合剂（供体）：它们仅在经历氧化应激的细胞中有选择性地隔离并灭活铁，从而限制了这些细胞中的氧化损伤。这些螯合剂是水杨醛异念珠菌（SIH）的化学修饰，我们发现能够保护培养的视网膜色素上皮细胞（RPE）免受多种侮辱引起的死亡。我们在此建议在RPE细胞中测试几个改良的SIH分子在细胞经历氧化应激时选择性减少不稳定铁池的能力，并确定螯合剂是否会增加细胞活力。初步结果表明，这些促教器在试管和RPE细胞中都被氧化应激激活，并且它们可以保护培养的RPE细胞免受氧化剂诱导的死亡。该提案的目的是确定具有最佳特征的支架：最大的RPE保护，最小的毒性。这些研究将为小鼠视网膜变性模型中的将来的培训试剂测试奠定基础。希望这些研究将为早期AMD患者提供新的预防剂。